Focus: Align Technology is a publicly traded medical device company specializing in teeth alignment solutions, with $3.9B in FY2025 revenue and dominant market position in clear aligner therapy.
Profile data last refreshed 11h ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Align Technology to get notified when they start hiring — the background below is worth knowing for when they do.
Flagship product driving majority of revenue and company valuation; represents the core competitive moat.
Help build intelligence for Align Technology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Align Technology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Product line extension addressing specific orthodontic indication; signals company strategy to expand indication footprint.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now - TradingView
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now TradingView
Align Technology Inc. stock (US0162551016): Invisalign maker in focus after recent share price swing - AD HOC NEWS
Align Technology Inc. stock (US0162551016): Invisalign maker in focus after recent share price swing AD HOC NEWS
Here's why you should retain AMN stock in your portfolio for now - MSN
Here's why you should retain AMN stock in your portfolio for now MSN
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? - TradingView
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? TradingView
Q1 2026 Life Sciences Earnings Review: PacBio vs. West Pharmaceutical Performance - News and Statistics - IndexBox
Q1 2026 Life Sciences Earnings Review: PacBio vs. West Pharmaceutical Performance - News and Statistics IndexBox
US-based Align Technology Plans INR 1,800 Cr Facility in Hyderabad - Digital Health News
US-based Align Technology Plans INR 1,800 Cr Facility in Hyderabad Digital Health News
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo